Off Patent
October 2027

Beleodaq

belinostat

Acrotech Biopharma Inc

Powder (intravenous) · NDA 206256

Last listed protection ends
October 27, 2027

The FDA lists 2 patents for Beleodaq, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 6,888,027
    Claims the drug substance, the drug product and a use (U-1544)
  2. Patent 8,835,501
    Claims the drug product